Mr. Beshear is accusing Johnson & Johnson of failing to follow recommendations by its own staff to include more complete disclosures of the risk for such devices. Transvaginal mesh is a synthetic woven fabric implanted through the vagina to treat common pelvic floor conditions that 30 to 50 percent of all women experience.
Mr. Beshear said in a statement that more than 15,000 women had transvaginal mesh implanted without Johnson & Johnson and Ethicon providing sufficient information about the known hazards so women and their physicians could make informed treatment decisions.
The lawsuit seeks millions of dollars in civil penalties under Kentucky’s Consumer Protection Act.
In an emailed response to the Associated Press Tuesday, the Johnson & Johnson subsidiary Ethicon called the lawsuits “unjustified.”
“The evidence will show that Ethicon acted appropriately and responsibly in the marketing of our pelvic mesh products,” the company said according to an Associated Press report published by The Washington Post. “The use of implantable mesh is often the preferred option to treat certain female pelvic conditions, including pelvic organ prolapse and stress urinary incontinence, and is backed by years of clinical research.”
Read the full lawsuit here.
More articles on healthcare industry lawsuits:
Teen accused of posing as physician may use insanity defense
26 latest healthcare industry lawsuits, settlements
Former Sacred Heart physician gets 2 years for role in kickback scheme
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
